Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-18

Clinical Trial Update: Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the efficacy of MAD as an add-on therapy to standard of care in children with autism spectrum disorder is ongoing with unknown stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Modified Atkins Diet, Autism Spectrum Disorder | Phase 2, Phase 3 | Status: UNKNOWN